GN Store Nord A/S (CPH:GN)
93.30
-2.18 (-2.28%)
Feb 27, 2026, 3:40 PM CET
GN Store Nord Market Cap
GN Store Nord has a market cap or net worth of 13.9 billion as of February 27, 2026. Its market cap has decreased by -33.72% in one year.
Market Cap
13.90B
Enterprise Value
23.60B
Revenue
16.78B
Ranking
n/a
PE Ratio
21.31
Stock Price
93.30
Market Cap Chart
Since March 30, 1993, GN Store Nord's market cap has increased from 330.14M to 13.90B, an increase of 4,111.21%. That is a compound annual growth rate of 12.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 13.54B | -12.90% |
| Dec 30, 2025 | 15.54B | -20.19% |
| Dec 30, 2024 | 19.48B | -22.12% |
| Dec 29, 2023 | 25.01B | 22.33% |
| Dec 30, 2022 | 20.44B | -61.08% |
| Dec 30, 2021 | 52.52B | -16.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.06T |
| Genmab | 112.86B |
| Coloplast | 108.53B |
| ALK-Abelló | 46.44B |
| H. Lundbeck | 37.97B |
| Zealand Pharma | 25.38B |
| Ambu A/S | 20.77B |
| Bavarian Nordic | 15.26B |